Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Voya Financial
VOYA
|
+$81.9M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$68.8M |
| 3 |
Goldman Sachs
GS
|
+$64.1M |
| 4 |
AbbVie
ABBV
|
+$58.2M |
| 5 |
Citigroup
C
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$85.8M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$60.3M |
| 3 |
Morgan Stanley
MS
|
+$52.6M |
| 4 |
Expedia Group
EXPE
|
+$47.8M |
| 5 |
Centene
CNC
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Financials | 14.02% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRLI
1776
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $3.52M | ﹤0.01% |
85,386
+12,902
| +18% | +$463K |
|
1777
MacroGenics
MGNX
$249M
| $3.52M | ﹤0.01% |
92,748
+26,320
| +40% | +$865K |
|
|
CRC
1778
DELISTED
California Resources Corporation
CRC
| $3.52M | ﹤0.01% |
58,277
+14,030
| +32% | +$1.13M |
|
|
CONN
1779
DELISTED
Conn's Inc.
CONN
| $3.51M | ﹤0.01% |
88,473
+8,146
| +10% | +$292K |
|
1780
The Ensign Group
ENSG
$10.5B
| $3.49M | ﹤0.01% |
146,271
-35,260
| -19% | -$774K |
|
1781
Materion
MTRN
$5.85B
| $3.49M | ﹤0.01% |
99,000
-18,641
| -16% | -$719K |
|
|
ABAX
1782
DELISTED
Abaxis Inc
ABAX
| $3.49M | ﹤0.01% |
67,736
+4,006
| +6% | +$225K |
|
1783
Super Micro Computer
SMCI
$20.4B
| $3.49M | ﹤0.01% |
1,178,720
+148,580
| +14% | +$489K |
|
1784
Nordic American Tanker
NAT
$1.31B
| $3.48M | ﹤0.01% |
246,641
-6,927
| -3% | -$88.7K |
|
|
FNFV
1785
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $3.47M | ﹤0.01% |
225,763
+99,486
| +79% | +$1.49M |
|
|
TERP
1786
DELISTED
TerraForm Power, Inc
TERP
| $3.47M | ﹤0.01% |
91,419
+8,694
| +11% | +$343K |
|
1787
Precigen
PGEN
$2.46B
| $3.47M | ﹤0.01% |
71,710
-54,659
| -43% | -$2.3M |
|
|
ZEN
1788
DELISTED
ZENDESK INC
ZEN
| $3.47M | ﹤0.01% |
156,149
+92,274
| +144% | +$2.12M |
|
1789
Hope Bancorp
HOPE
$1.82B
| $3.46M | ﹤0.01% |
234,214
+7,163
| +3% | +$105K |
|
|
OWW
1790
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $3.46M | ﹤0.01% |
302,626
+108,682
| +56% | +$1.26M |
|
1791
Exponent
EXPO
$3.25B
| $3.45M | ﹤0.01% |
154,200
+4,468
| +3% | +$98.1K |
|
|
NEWP
1792
DELISTED
NEWPORT CORP
NEWP
| $3.45M | ﹤0.01% |
181,871
-23,470
| -11% | -$455K |
|
1793
HealthEquity
HQY
$8.83B
| $3.44M | ﹤0.01% |
107,467
+85,074
| +380% | +$2.28M |
|
1794
OFG Bancorp
OFG
$2.22B
| $3.44M | ﹤0.01% |
322,559
-75,728
| -19% | -$1.09M |
|
|
WAC
1795
DELISTED
Walter Investment Mgt Corp
WAC
| $3.43M | ﹤0.01% |
149,800
+30,892
| +26% | +$589K |
|
1796
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $3.41M | ﹤0.01% |
80,000
-18,800
| -19% | -$817K |
|
|
STNR
1797
DELISTED
STEINER LEISURE LTD
STNR
| $3.41M | ﹤0.01% |
63,322
+3,742
| +6% | +$189K |
|
1798
BJ's Restaurants
BJRI
$1.44B
| $3.4M | ﹤0.01% |
70,155
+2,070
| +3% | +$99.9K |
|
|
RLD
1799
DELISTED
REALD INC COM STK
RLD
| $3.4M | ﹤0.01% |
275,583
-62,480
| -18% | -$782K |
|
1800
TherapeuticsMD
TXMD
$24M
| $3.39M | ﹤0.01% |
8,633
+245
| +3% | +$86.4K |
|
Similar funds
Charles Schwab's Q2 2015 Portfolio in Review
As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
- Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
- Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
- Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
- Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
- Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
- Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.
Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.